The Vasculome of the Mouse Brain

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Guo, Shuzhen ^a   Zhou, Yiming ^a,b   Xing, Changhong ^a   Lok, Josephine ^a   Som, Angel T ^a   Ning, MingMing ^a   Ji, Xunming ^c   Lo, Eng H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOMOTIN; ATAXIN 1; BIOLOGICAL MARKER; CD2 ASSOCIATED PROTEIN; MEMBRANE PROTEIN; P21 ACTIVATED KINASE; RNA; UNCLASSIFIED DRUG; WNT PROTEIN;

ALZHEIMER DISEASE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN BLOOD VESSEL; BRAIN NERVE CELL; CELL ADHESION; CELL MEMBRANE; CELL TRANSPORT; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; GENETIC ASSOCIATION; GLOMERULUS; HEART MUSCLE CELL; KIDNEY TUBULE CELL; LEUKOCYTE MIGRATION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OLIGODENDROGLIA; PARKINSON DISEASE; RNA EXTRACTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD PROTEINS; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; CLUSTER ANALYSIS; DATABASES, PROTEIN; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN BINDING; PROTEIN INTERACTION MAPS; PROTEOME; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84871441043     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052665     Document Type: Article

References (208)

1. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, et al. (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 42: 2672-2713.
2. Guo S, Lo EH, (2009) Dysfunctional cell-cell signaling in the neurovascular unit as a paradigm for central nervous system disease. Stroke 40: S4-7.
3. Lecrux C, Hamel E, (2011) The neurovascular unit in brain function and disease. Acta Physiol (Oxf) 203: 47-59.
4. Zlokovic BV, (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12: 723-738.
5. Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, et al. (2010) Glial and neuronal control of brain blood flow. Nature 468: 232-243.
6. Abbott NJ, (2002) Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 200: 629-638.
7. Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, et al. (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature. 485: 512-516.
8. Ronaldson PT, Davis TP, (2012) Blood-Brain Barrier Integrity and Glial Support: Mechanisms that can be Targeted for Novel Therapeutic Approaches in Stroke. Curr Pharm Des 18: 3624-3644.
9. Zacchigna S, Ruiz de Almodovar C, Carmeliet P, (2008) Similarities between angiogenesis and neural development: what small animal models can tell us. Curr Top Dev Biol 80: 1-55.
10. Shen Q, Goderie SK, Jin L, Karanth N, Sun Y, et al. (2004) Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304: 1338-1340.
11. Dugas JC, Mandemakers W, Rogers M, Ibrahim A, Daneman R, et al. (2008) A novel purification method for CNS projection neurons leads to the identification of brain vascular cells as a source of trophic support for corticospinal motor neurons. J Neurosci 28: 8294-8305.
12. Guo S, Kim WJ, Lok J, Lee SR, Besancon E, et al. (2008) Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons. Proc Natl Acad Sci U S A 105: 7582-7587.
13. Leventhal C, Rafii S, Rafii D, Shahar A, Goldman SA, (1999) Endothelial trophic support of neuronal production and recruitment from the adult mammalian subependyma. Mol Cell Neurosci 13: 450-464.
14. Guo S, Som AT, Waeber C, Lo EH, (2012) Vascular neuroprotection via TrkB- and Akt-dependent cell survival signaling. J Neurochem 123Suppl 2: 58-64.
15. Navaratna D, Guo SZ, Hayakawa K, Wang X, Gerhardinger C, et al. (2011) Decreased cerebrovascular brain-derived neurotrophic factor-mediated neuroprotection in the diabetic brain. Diabetes 60: 1789-1796.
16. Garbuzova-Davis S, Rodrigues MC, Hernandez-Ontiveros DG, Louis MK, Willing AE, et al. (2011) Amyotrophic lateral sclerosis: a neurovascular disease. Brain Res 1398: 113-125.
17. Neuwelt EA, Bauer B, Fahlke C, Fricker G, Iadecola C, et al. (2011) Engaging neuroscience to advance translational research in brain barrier biology. Nat Rev Neurosci 12: 169-182.
18. Zlokovic BV, (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57: 178-201.
19. Daneman R, Zhou L, Agalliu D, Cahoy JD, Kaushal A, et al. (2010) The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PLoS One 5: e13741.
20. Enerson BE, Drewes LR, (2006) The rat blood-brain barrier transcriptome. J Cereb Blood Flow Metab 26: 959-973.
21. Pardridge WM, (2007) Blood-brain barrier genomics. Stroke 38: 686-690.
22. Wallgard E, Larsson E, He L, Hellstrom M, Armulik A, et al. (2008) Identification of a core set of 58 gene transcripts with broad and specific expression in the microvasculature. Arterioscler Thromb Vasc Biol 28: 1469-1476.
23. Dougherty JD, Schmidt EF, Nakajima M, Heintz N, (2010) Analytical approaches to RNA profiling data for the identification of genes enriched in specific cells. Nucleic Acids Res 38: 4218-4230.
24. Doyle JP, Dougherty JD, Heiman M, Schmidt EF, Stevens TR, et al. (2008) Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell 135: 749-762.
25. Andras IE, Deli MA, Veszelka S, Hayashi K, Hennig B, et al. (2007) The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells. J Cereb Blood Flow Metab 27: 1431-1443.
26. Parfenova H, Fedinec A, Leffler CW, (2003) Ionotropic glutamate receptors in cerebral microvascular endothelium are functionally linked to heme oxygenase. J Cereb Blood Flow Metab 23: 190-197.
27. Collard CD, Park KA, Montalto MC, Alapati S, Buras JA, et al. (2002) Neutrophil-derived glutamate regulates vascular endothelial barrier function. J Biol Chem 277: 14801-14811.
28. Beard RS Jr, Reynolds JJ, Bearden SE, (2011) Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions. Blood 118: 2007-2014.
29. Mayo JN, Beard RS Jr, Price TO, Chen CH, Erickson MA, et al. (2012) Nitrative stress in cerebral endothelium is mediated by mGluR5 in hyperhomocysteinemia. J Cereb Blood Flow Metab 32: 825-834.
30. Helms HC, Madelung R, Waagepetersen HS, Nielsen CU, Brodin B, (2012) In vitro evidence for the brain glutamate efflux hypothesis: brain endothelial cells cocultured with astrocytes display a polarized brain-to-blood transport of glutamate. Glia 60: 882-893.
31. Pasterkamp RJ, Giger RJ, (2009) Semaphorin function in neural plasticity and disease. Curr Opin Neurobiol 19: 263-274.
32. Kruger RP, Aurandt J, Guan KL, (2005) Semaphorins command cells to move. Nat Rev Mol Cell Biol 6: 789-800.
33. Sakurai A, Doci CL, Gutkind JS, (2012) Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer. Cell Res 22: 23-32.
34. Banu N, Teichman J, Dunlap-Brown M, Villegas G, Tufro A, (2006) Semaphorin 3C regulates endothelial cell function by increasing integrin activity. FASEB J 20: 2150-2152.
35. Conrotto P, Valdembri D, Corso S, Serini G, Tamagnone L, et al. (2005) Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood 105: 4321-4329.
36. Arese M, Serini G, Bussolino F, (2011) Nervous vascular parallels: axon guidance and beyond. Int J Dev Biol 55: 439-445.
37. Krizbai IA, Deli MA, Pestenacz A, Siklos L, Szabo CA, et al. (1998) Expression of glutamate receptors on cultured cerebral endothelial cells. J Neurosci Res 54: 814-819.
38. Deli MA, Joo F, Krizbai I, Lengyel I, Nunzi MG, et al. (1993) Calcium/calmodulin-stimulated protein kinase II is present in primary cultures of cerebral endothelial cells. J Neurochem 60: 1960-1963.
39. Sakurai T, (2012) The role of NrCAM in neural development and disorders-beyond a simple glue in the brain. Mol Cell Neurosci 49: 351-363.
40. Demyanenko GP, Riday TT, Tran TS, Dalal J, Darnell EP, et al. (2011) NrCAM deletion causes topographic mistargeting of thalamocortical axons to the visual cortex and disrupts visual acuity. J Neurosci 31: 1545-1558.
41. Moy SS, Nonneman RJ, Young NB, Demyanenko GP, Maness PF, (2009) Impaired sociability and cognitive function in Nrcam-null mice. Behav Brain Res 205: 123-131.
42. Nadadur SS, Haykal-Coates N, Mudipalli A, Costa DL, (2009) Endothelial effects of emission source particles: acute toxic response gene expression profiles. Toxicol In Vitro 23: 67-77.
43. Glienke J, Schmitt AO, Pilarsky C, Hinzmann B, Weiss B, et al. (2000) Differential gene expression by endothelial cells in distinct angiogenic states. Eur J Biochem 267: 2820-2830.
44. Bottos A, Destro E, Rissone A, Graziano S, Cordara G, et al. (2009) The synaptic proteins neurexins and neuroligins are widely expressed in the vascular system and contribute to its functions. Proc Natl Acad Sci U S A 106: 20782-20787.
45. Chui R, Dorovini-Zis K, (2010) Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide. J Neuroinflammation 7: 1.
46. Tripathy D, Thirumangalakudi L, Grammas P, (2007) Expression of macrophage inflammatory protein 1-alpha is elevated in Alzheimer's vessels and is regulated by oxidative stress. J Alzheimers Dis 11: 447-455.
47. Homey B, Alenius H, Muller A, Soto H, Bowman EP, et al. (2002) CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 8: 157-165.
48. Baird JW, Nibbs RJ, Komai-Koma M, Connolly JA, Ottersbach K, et al. (1999) ESkine, a novel beta-chemokine, is differentially spliced to produce secretable and nuclear targeted isoforms. J Biol Chem 274: 33496-33503.
49. Nibbs RJ, Graham GJ, (2003) CCL27/PESKY: a novel paradigm for chemokine function. Expert Opin Biol Ther 3: 15-22.
50. Liu C, Gelius E, Liu G, Steiner H, Dziarski R, (2000) Mammalian peptidoglycan recognition protein binds peptidoglycan with high affinity, is expressed in neutrophils, and inhibits bacterial growth. J Biol Chem 275: 24490-24499.
51. Dukhanina EA, Romanova EA, Dukhanin AS, Kabanova OD, Lukyanova TI, et al. (2008) Interactions and possible functional characteristics of Tag7-S100A4 protein complex. Bull Exp Biol Med 145: 191-193.
52. Yashin DV, Dukhanina EA, Kabanova OD, Romanova EA, Lukyanova TI, et al. (2011) The heat shock-binding protein (HspBP1) protects cells against the cytotoxic action of the Tag7-Hsp70 complex. J Biol Chem 286: 10258-10264.
53. Rehman A, Taishi P, Fang J, Majde JA, Krueger JM, (2001) The cloning of a rat peptidoglycan recognition protein (PGRP) and its induction in brain by sleep deprivation. Cytokine 13: 8-17.
54. Frey RS, Ushio-Fukai M, Malik AB, (2009) NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxid Redox Signal 11: 791-810.
55. Chrissobolis S, Faraci FM, (2008) The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Trends Mol Med 14: 495-502.
56. Askarova S, Yang X, Sheng W, Sun GY, Lee JC, (2011) Role of Abeta-receptor for advanced glycation endproducts interaction in oxidative stress and cytosolic phospholipase A(2) activation in astrocytes and cerebral endothelial cells. Neuroscience 199: 375-385.
57. Kristensen AS, Andersen J, Jorgensen TN, Sorensen L, Eriksen J, et al. (2011) SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev 63: 585-640.
58. Krizbai I, Szabo G, Deli M, Maderspach K, Lehel C, et al. (1995) Expression of protein kinase C family members in the cerebral endothelial cells. J Neurochem 65: 459-462.
59. Yang T, Roder KE, Bhat GJ, Thekkumkara TJ, Abbruscato TJ, (2006) Protein kinase C family members as a target for regulation of blood-brain barrier Na,K,2Cl-cotransporter during in vitro stroke conditions and nicotine exposure. Pharm Res 23: 291-302.
60. Fleegal MA, Hom S, Borg LK, Davis TP, (2005) Activation of PKC modulates blood-brain barrier endothelial cell permeability changes induced by hypoxia and posthypoxic reoxygenation. Am J Physiol Heart Circ Physiol 289: H2012-2019.
61. Park M, Shen K, (2012) WNTs in synapse formation and neuronal circuitry. EMBO J 31: 2697-2704.
62. Varela-Nallar L, Alfaro IE, Serrano FG, Parodi J, Inestrosa NC, (2010) Wingless-type family member 5A (Wnt-5a) stimulates synaptic differentiation and function of glutamatergic synapses. Proc Natl Acad Sci U S A 107: 21164-21169.
63. Kalani MY, Cheshier SH, Cord BJ, Bababeygy SR, Vogel H, et al. (2008) Wnt-mediated self-renewal of neural stem/progenitor cells. Proc Natl Acad Sci U S A 105: 16970-16975.
64. Zechner D, Fujita Y, Hulsken J, Muller T, Walther I, et al. (2003) beta-Catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system. Dev Biol 258: 406-418.
65. Tam SJ, Richmond DL, Kaminker JS, Modrusan Z, Martin-McNulty B, et al. (2012) Death receptors DR6 and TROY regulate brain vascular development. Dev Cell 22: 403-417.
66. Stenman JM, Rajagopal J, Carroll TJ, Ishibashi M, McMahon J, et al. (2008) Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science 322: 1247-1250.
67. Liebner S, Corada M, Bangsow T, Babbage J, Taddei A, et al. (2008) Wnt/beta-catenin signaling controls development of the blood-brain barrier. J Cell Biol 183: 409-417.
68. Daneman R, Agalliu D, Zhou L, Kuhnert F, Kuo CJ, et al. (2009) Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc Natl Acad Sci U S A 106: 641-646.
69. Chong ZZ, Shang YC, Maiese K, (2007) Vascular injury during elevated glucose can be mitigated by erythropoietin and Wnt signaling. Curr Neurovasc Res 4: 194-204.
70. Fancy SP, Harrington EP, Yuen TJ, Silbereis JC, Zhao C, et al. (2011) Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci 14: 1009-1016.
71. Diep DB, Hoen N, Backman M, Machon O, Krauss S, (2004) Characterisation of the Wnt antagonists and their response to conditionally activated Wnt signalling in the developing mouse forebrain. Brain Res Dev Brain Res 153: 261-270.
72. Pi X, Wu Y, Ferguson JE 3rd, Portbury AL, Patterson C (2009) SDF-1alpha stimulates JNK3 activity via eNOS-dependent nitrosylation of MKP7 to enhance endothelial migration. Proc Natl Acad Sci U S A 106: 5675-5680.
73. Planutiene M, Planutis K, Holcombe RF, (2011) Lymphoid enhancer-binding factor 1, a representative of vertebrate-specific Lef1/Tcf1 sub-family, is a Wnt-beta-catenin pathway target gene in human endothelial cells which regulates matrix metalloproteinase-2 expression and promotes endothelial cell invasion. Vasc Cell 3: 28.
74. Phng LK, Potente M, Leslie JD, Babbage J, Nyqvist D, et al. (2009) Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis. Dev Cell 16: 70-82.
75. GrandPre T, Li S, Strittmatter SM, (2002) Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 417: 547-551.
76. Acevedo L, Yu J, Erdjument-Bromage H, Miao RQ, Kim JE, et al. (2004) A new role for Nogo as a regulator of vascular remodeling. Nat Med 10: 382-388.
77. Di Lorenzo A, Manes TD, Davalos A, Wright PL, Sessa WC, (2011) Endothelial reticulon-4B (Nogo-B) regulates ICAM-1-mediated leukocyte transmigration and acute inflammation. Blood 117: 2284-2295.
78. Yu J, Fernandez-Hernando C, Suarez Y, Schleicher M, Hao Z, et al. (2009) Reticulon 4B (Nogo-B) is necessary for macrophage infiltration and tissue repair. Proc Natl Acad Sci U S A 106: 17511-17516.
79. de Haan JB, Cristiano F, Iannello RC, Kola I, (1995) Cu/Zn-superoxide dismutase and glutathione peroxidase during aging. Biochem Mol Biol Int 35: 1281-1297.
80. Crack PJ, Cimdins K, Ali U, Hertzog PJ, Iannello RC, (2006) Lack of glutathione peroxidase-1 exacerbates Abeta-mediated neurotoxicity in cortical neurons. J Neural Transm 113: 645-657.
81. Aase K, Ernkvist M, Ebarasi L, Jakobsson L, Majumdar A, et al. (2007) Angiomotin regulates endothelial cell migration during embryonic angiogenesis. Genes Dev 21: 2055-2068.
82. Ishibashi N, Prokopenko O, Weisbrot-Lefkowitz M, Reuhl KR, Mirochnitchenko O, (2002) Glutathione peroxidase inhibits cell death and glial activation following experimental stroke. Brain Res Mol Brain Res 109: 34-44.
83. Xiong Y, Shie FS, Zhang J, Lee CP, Ho YS, (2004) The protective role of cellular glutathione peroxidase against trauma-induced mitochondrial dysfunction in the mouse brain. J Stroke Cerebrovasc Dis 13: 129-137.
84. Wong CH, Bozinovski S, Hertzog PJ, Hickey MJ, Crack PJ, (2008) Absence of glutathione peroxidase-1 exacerbates cerebral ischemia-reperfusion injury by reducing post-ischemic microvascular perfusion. J Neurochem 107: 241-252.
85. Ishibashi N, Prokopenko O, Reuhl KR, Mirochnitchenko O, (2002) Inflammatory response and glutathione peroxidase in a model of stroke. J Immunol 168: 1926-1933.
86. Tajima M, Kurashima Y, Sugiyama K, Ogura T, Sakagami H, (2009) The redox state of glutathione regulates the hypoxic induction of HIF-1. Eur J Pharmacol 606: 45-49.
87. Galasso G, Schiekofer S, Sato K, Shibata R, Handy DE, et al. (2006) Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circ Res 98: 254-261.
88. Greenberg DA, Jin K, (2005) From angiogenesis to neuropathology. Nature 438: 954-959.
89. Sun Y, Jin K, Xie L, Childs J, Mao XO, et al. (2003) VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 111: 1843-1851.
90. Gandhi S, Wood NW, (2010) Genome-wide association studies: the key to unlocking neurodegeneration? Nat Neurosci 13: 789-794.
91. Tossidou I, Kardinal C, Peters I, Kriz W, Shaw A, et al. (2007) CD2AP/CIN85 balance determines receptor tyrosine kinase signaling response in podocytes. J Biol Chem 282: 7457-7464.
92. Li C, Ruotsalainen V, Tryggvason K, Shaw AS, Miner JH, (2000) CD2AP is expressed with nephrin in developing podocytes and is found widely in mature kidney and elsewhere. Am J Physiol Renal Physiol 279: F785-792.
93. Bokoch GM, (1998) Caspase-mediated activation of PAK2 during apoptosis: proteolytic kinase activation as a general mechanism of apoptotic signal transduction? Cell Death Differ 5: 637-645.
94. Buchner DA, Su F, Yamaoka JS, Kamei M, Shavit JA, et al. (2007) pak2a mutations cause cerebral hemorrhage in redhead zebrafish. Proc Natl Acad Sci U S A 104: 13996-14001.
95. Goeckeler ZM, Masaracchia RA, Zeng Q, Chew TL, Gallagher P, et al. (2000) Phosphorylation of myosin light chain kinase by p21-activated kinase PAK2. J Biol Chem 275: 18366-18374.
96. Zeng Q, Lagunoff D, Masaracchia R, Goeckeler Z, Cote G, et al. (2000) Endothelial cell retraction is induced by PAK2 monophosphorylation of myosin II. J Cell Sci 113 (Pt 3): 471-482.
97. Gavard J, Gutkind JS, (2006) VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 8: 1223-1234.
98. Demyanenko GP, Halberstadt AI, Rao RS, Maness PF, (2010) CHL1 cooperates with PAK1-3 to regulate morphological differentiation of embryonic cortical neurons. Neuroscience 165: 107-115.
99. Zoghbi HY, Orr HT, (2009) Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1. J Biol Chem 284: 7425-7429.
100. Matilla-Duenas A, Goold R, Giunti P, (2008) Clinical, genetic, molecular, and pathophysiological insights into spinocerebellar ataxia type 1. Cerebellum 7: 106-114.
101. Tong X, Gui H, Jin F, Heck BW, Lin P, et al. (2011) Ataxin-1 and Brother of ataxin-1 are components of the Notch signalling pathway. EMBO Rep 12: 428-435.
102. Lam YC, Bowman AB, Jafar-Nejad P, Lim J, Richman R, et al. (2006) ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell 127: 1335-1347.
103. Tsai CC, Kao HY, Mitzutani A, Banayo E, Rajan H, et al. (2004) Ataxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors. Proc Natl Acad Sci U S A 101: 4047-4052.
104. Al-Ramahi I, Lam YC, Chen HK, de Gouyon B, Zhang M, et al. (2006) CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation. J Biol Chem 281: 26714-26724.
105. Zhang C, Browne A, Child D, Divito JR, Stevenson JA, et al. (2010) Loss of function of ATXN1 increases amyloid beta-protein levels by potentiating beta-secretase processing of beta-amyloid precursor protein. J Biol Chem 285: 8515-8526.
106. Bratt A, Birot O, Sinha I, Veitonmaki N, Aase K, et al. (2005) Angiomotin regulates endothelial cell-cell junctions and cell motility. J Biol Chem 280: 34859-34869.
107. Troyanovsky B, Levchenko T, Mansson G, Matvijenko O, Holmgren L, (2001) Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol 152: 1247-1254.
108. Zhao B, Li L, Lu Q, Wang LH, Liu CY, et al. (2011) Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 25: 51-63.
109. Ernkvist M, Aase K, Ukomadu C, Wohlschlegel J, Blackman R, et al. (2006) p130-angiomotin associates to actin and controls endothelial cell shape. FEBS J 273: 2000-2011.
110. Ernkvist M, Birot O, Sinha I, Veitonmaki N, Nystrom S, et al. (2008) Differential roles of p80- and p130-angiomotin in the switch between migration and stabilization of endothelial cells. Biochim Biophys Acta 1783: 429-437.
111. Roudier E, Chapados N, Decary S, Gineste C, Le Bel C, et al. (2009) Angiomotin p80/p130 ratio: a new indicator of exercise-induced angiogenic activity in skeletal muscles from obese and non-obese rats? J Physiol 587: 4105-4119.
112. Lorber B, Howe ML, Benowitz LI, Irwin N, (2009) Mst3b, an Ste20-like kinase, regulates axon regeneration in mature CNS and PNS pathways. Nat Neurosci 12: 1407-1414.
113. Irwin N, Li YM, O'Toole JE, Benowitz LI, (2006) Mst3b, a purine-sensitive Ste20-like protein kinase, regulates axon outgrowth. Proc Natl Acad Sci U S A 103: 18320-18325.
114. Huang CY, Wu YM, Hsu CY, Lee WS, Lai MD, et al. (2002) Caspase activation of mammalian sterile 20-like kinase 3 (Mst3). Nuclear translocation and induction of apoptosis. J Biol Chem 277: 34367-34374.
115. Lu TJ, Lai WY, Huang CY, Hsieh WJ, Yu JS, et al. (2006) Inhibition of cell migration by autophosphorylated mammalian sterile 20-like kinase 3 (MST3) involves paxillin and protein-tyrosine phosphatase-PEST. J Biol Chem 281: 38405-38417.
116. Stegert MR, Hergovich A, Tamaskovic R, Bichsel SJ, Hemmings BA, (2005) Regulation of NDR protein kinase by hydrophobic motif phosphorylation mediated by the mammalian Ste20-like kinase MST3. Mol Cell Biol 25: 11019-11029.
117. Zach S, Felk S, Gillardon F, (2010) Signal transduction protein array analysis links LRRK2 to Ste20 kinases and PKC zeta that modulate neuronal plasticity. PLoS One 5: e13191.
118. Zheng X, Xu C, Di Lorenzo A, Kleaveland B, Zou Z, et al. (2010) CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. J Clin Invest 120: 2795-2804.
119. Tsang S, Woo AY, Zhu W, Xiao RP, (2010) Deregulation of RGS2 in cardiovascular diseases. Front Biosci (Schol Ed) 2: 547-557.
120. Osei-Owusu P, Sabharwal R, Kaltenbronn KM, Rhee MH, Chapleau MW, et al. (2012) Regulator of G protein signaling 2 deficiency causes endothelial dysfunction and impaired endothelium-derived hyperpolarizing factor-mediated relaxation by dysregulating Gi/o signaling. J Biol Chem 287: 12541-12549.
121. Lifschytz T, Broner EC, Zozulinsky P, Slonimsky A, Eitan R, et al. (2011) Relationship between Rgs2 gene expression level and anxiety and depression-like behaviour in a mutant mouse model: serotonergic involvement. Int J Neuropsychopharmacol: 1-12.
122. Smoller JW, Paulus MP, Fagerness JA, Purcell S, Yamaki LH, et al. (2008) Influence of RGS2 on anxiety-related temperament, personality, and brain function. Arch Gen Psychiatry 65: 298-308.
123. Doupnik CA, Davidson N, Lester HA, Kofuji P, (1997) RGS proteins reconstitute the rapid gating kinetics of gbetagamma-activated inwardly rectifying K+ channels. Proc Natl Acad Sci U S A 94: 10461-10466.
124. Han J, Mark MD, Li X, Xie M, Waka S, et al. (2006) RGS2 determines short-term synaptic plasticity in hippocampal neurons by regulating Gi/o-mediated inhibition of presynaptic Ca2+ channels. Neuron 51: 575-586.
125. Hutchison RM, Chidiac P, Leung LS, (2009) Hippocampal long-term potentiation is enhanced in urethane-anesthetized RGS2 knockout mice. Hippocampus 19: 687-691.
126. Kammermeier PJ, Ikeda SR, (1999) Expression of RGS2 alters the coupling of metabotropic glutamate receptor 1a to M-type K+ and N-type Ca2+ channels. Neuron 22: 819-829.
127. Xiao R, Tang P, Yang B, Huang J, Zhou Y, et al. (2012) Nuclear matrix factor hnRNP U/SAF-A exerts a global control of alternative splicing by regulating U2 snRNP maturation. Mol Cell 45: 656-668.
128. Kukalev A, Nord Y, Palmberg C, Bergman T, Percipalle P, (2005) Actin and hnRNP U cooperate for productive transcription by RNA polymerase II. Nat Struct Mol Biol 12: 238-244.
129. Zhao W, Wang L, Zhang M, Wang P, Qi J, et al. (2012) Nuclear to cytoplasmic translocation of heterogeneous nuclear ribonucleoprotein U enhances TLR-induced proinflammatory cytokine production by stabilizing mRNAs in macrophages. J Immunol 188: 3179-3187.
130. Capon F, Bijlmakers MJ, Wolf N, Quaranta M, Huffmeier U, et al. (2008) Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene. Hum Mol Genet 17: 1938-1945.
131. Bijlmakers MJ, Kanneganti SK, Barker JN, Trembath RC, Capon F, (2011) Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis. Hum Mol Genet 20: 3129-3137.
132. Tsyba L, Nikolaienko O, Dergai O, Dergai M, Novokhatska O, et al. (2011) Intersectin multidomain adaptor proteins: regulation of functional diversity. Gene 473: 67-75.
133. Seifert M, Ampofo C, Mehraein Y, Reichrath J, Welter C, (2007) Expression analysis of human intersectin 2 gene (ITSN2) minor splice variants showing differential expression in normal human brain. Oncol Rep 17: 1207-1211.
134. Klein IK, Predescu DN, Sharma T, Knezevic I, Malik AB, et al. (2009) Intersectin-2L regulates caveola endocytosis secondary to Cdc42-mediated actin polymerization. J Biol Chem 284: 25953-25961.
135. Causeret F, Terao M, Jacobs T, Nishimura YV, Yanagawa Y, et al. (2009) The p21-activated kinase is required for neuronal migration in the cerebral cortex. Cereb Cortex 19: 861-875.
136. Schmid RS, Midkiff BR, Kedar VP, Maness PF, (2004) Adhesion molecule L1 stimulates neuronal migration through Vav2-Pak1 signaling. Neuroreport 15: 2791-2794.
137. Zhang H, Webb DJ, Asmussen H, Niu S, Horwitz AF, (2005) A GIT1/PIX/Rac/PAK signaling module regulates spine morphogenesis and synapse formation through MLC. J Neurosci 25: 3379-3388.
138. de la Torre-Ubieta L, Gaudilliere B, Yang Y, Ikeuchi Y, Yamada T, et al. (2010) A FOXO-Pak1 transcriptional pathway controls neuronal polarity. Genes Dev 24: 799-813.
139. Asrar S, Meng Y, Zhou Z, Todorovski Z, Huang WW, et al. (2009) Regulation of hippocampal long-term potentiation by p21-activated protein kinase 1 (PAK1). Neuropharmacology 56: 73-80.
140. Hayashi ML, Rao BS, Seo JS, Choi HS, Dolan BM, et al. (2007) Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice. Proc Natl Acad Sci U S A 104: 11489-11494.
141. Chen SY, Huang PH, Cheng HJ, (2011) Disrupted-in-Schizophrenia 1-mediated axon guidance involves TRIO-RAC-PAK small GTPase pathway signaling. Proc Natl Acad Sci U S A 108: 5861-5866.
142. Tudor EL, Perkinton MS, Schmidt A, Ackerley S, Brownlees J, et al. (2005) ALS2/Alsin regulates Rac-PAK signaling and neurite outgrowth. J Biol Chem 280: 34735-34740.
143. Li W, Guan KL, (2004) The Down syndrome cell adhesion molecule (DSCAM) interacts with and activates Pak. J Biol Chem 279: 32824-32831.
144. Ke Y, Lum H, Solaro RJ, (2007) Inhibition of endothelial barrier dysfunction by P21-activated kinase-1. Can J Physiol Pharmacol 85: 281-288.
145. Stockton R, Reutershan J, Scott D, Sanders J, Ley K, et al. (2007) Induction of vascular permeability: beta PIX and GIT1 scaffold the activation of extracellular signal-regulated kinase by PAK. Mol Biol Cell 18: 2346-2355.
146. Kanda S, Miyata Y, Kanetake H, (2004) Role of focal adhesion formation in migration and morphogenesis of endothelial cells. Cell Signal 16: 1273-1281.
147. Rudrabhatla RS, Selvaraj SK, Prasadarao NV, (2006) Role of Rac1 in Escherichia coli K1 invasion of human brain microvascular endothelial cells. Microbes Infect 8: 460-469.
148. Rudrabhatla RS, Sukumaran SK, Bokoch GM, Prasadarao NV, (2003) Modulation of myosin light-chain phosphorylation by p21-activated kinase 1 in Escherichia coli invasion of human brain microvascular endothelial cells. Infect Immun 71: 2787-2797.
149. D'Arcy P, Brnjic S, Olofsson MH, Fryknas M, Lindsten K, et al. (2011) Inhibition of proteasome deubiquitinating activity as a new cancer therapy. Nat Med 17: 1636-1640.
150. Mazumdar T, Gorgun FM, Sha Y, Tyryshkin A, Zeng S, et al. (2010) Regulation of NF-kappaB activity and inducible nitric oxide synthase by regulatory particle non-ATPase subunit 13 (Rpn13). Proc Natl Acad Sci U S A 107: 13854-13859.
151. Yao T, Song L, Xu W, DeMartino GN, Florens L, et al. (2006) Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1. Nat Cell Biol 8: 994-1002.
152. Yao T, Song L, Jin J, Cai Y, Takahashi H, et al. (2008) Distinct modes of regulation of the Uch37 deubiquitinating enzyme in the proteasome and in the Ino80 chromatin-remodeling complex. Mol Cell 31: 909-917.
153. Wicks SJ, Haros K, Maillard M, Song L, Cohen RE, et al. (2005) The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-beta signalling. Oncogene 24: 8080-8084.
154. Nguyen HL, Lee YJ, Shin J, Lee E, Park SO, et al. (2011) TGF-beta signaling in endothelial cells, but not neuroepithelial cells, is essential for cerebral vascular development. Lab Invest 91: 1554-1563.
155. Robson A, Allinson KR, Anderson RH, Henderson DJ, Arthur HM, (2010) The TGFbeta type II receptor plays a critical role in the endothelial cells during cardiac development. Dev Dyn 239: 2435-2442.
156. Falk S, Wurdak H, Ittner LM, Ille F, Sumara G, et al. (2008) Brain area-specific effect of TGF-beta signaling on Wnt-dependent neural stem cell expansion. Cell Stem Cell 2: 472-483.
157. Rzymski T, Petry A, Kracun D, Riess F, Pike L, et al. (2012) The unfolded protein response controls induction and activation of ADAM17/TACE by severe hypoxia and ER stress. Oncogene 31: 3621-3634.
158. Yoshikawa T, Ogata N, Izuta H, Shimazawa M, Hara H, et al. (2011) Increased expression of tight junctions in ARPE-19 cells under endoplasmic reticulum stress. Curr Eye Res 36: 1153-1163.
159. Salminen A, Kauppinen A, Hyttinen JM, Toropainen E, Kaarniranta K, (2010) Endoplasmic reticulum stress in age-related macular degeneration: trigger for neovascularization. Mol Med 16: 535-542.
160. Reisman DN, Sciarrotta J, Bouldin TW, Weissman BE, Funkhouser WK, (2005) The expression of the SWI/SNF ATPase subunits BRG1 and BRM in normal human tissues. Appl Immunohistochem Mol Morphol 13: 66-74.
161. Wang F, Zhang R, Beischlag TV, Muchardt C, Yaniv M, et al. (2004) Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene. J Biol Chem 279: 46733-46741.
162. Koga M, Ishiguro H, Yazaki S, Horiuchi Y, Arai M, et al. (2009) Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia. Hum Mol Genet 18: 2483-2494.
163. Jung BP, Zhang G, Ho W, Francis J, Eubanks JH, (2002) Transient forebrain ischemia alters the mRNA expression of methyl DNA-binding factors in the adult rat hippocampus. Neuroscience 115: 515-524.
164. Rao X, Zhong J, Zhang S, Zhang Y, Yu Q, et al. (2011) Loss of methyl-CpG-binding domain protein 2 enhances endothelial angiogenesis and protects mice against hind-limb ischemic injury. Circulation 123: 2964-2974.
165. Laflamme N, Rivest S, (1999) Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kappaB alpha within specific cellular populations of the rat brain. J Neurochem 73: 309-321.
166. Blais V, Rivest S, (2001) Inhibitory action of nitric oxide on circulating tumor necrosis factor-induced NF-kappaB activity and COX-2 transcription in the endothelium of the brain capillaries. J Neuropathol Exp Neurol 60: 893-905.
167. McCormick JA, Ellison DH, (2011) The WNKs: atypical protein kinases with pleiotropic actions. Physiol Rev 91: 177-219.
168. Bergaya S, Faure S, Baudrie V, Rio M, Escoubet B, et al. (2011) WNK1 regulates vasoconstriction and blood pressure response to alpha 1-adrenergic stimulation in mice. Hypertension 58: 439-445.
169. Flatman PW, (2008) Cotransporters, WNKs and hypertension: an update. Curr Opin Nephrol Hypertens 17: 186-192.
170. Xie J, Wu T, Xu K, Huang IK, Cleaver O, et al. (2009) Endothelial-specific expression of WNK1 kinase is essential for angiogenesis and heart development in mice. Am J Pathol 175: 1315-1327.
171. Zhang Z, Xu X, Zhang Y, Zhou J, Yu Z, et al. (2009) LINGO-1 interacts with WNK1 to regulate nogo-induced inhibition of neurite extension. J Biol Chem 284: 15717-15728.
172. Manunta P, Citterio L, Lanzani C, Ferrandi M, (2007) Adducin polymorphisms and the treatment of hypertension. Pharmacogenomics 8: 465-472.
173. Lanzani C, Citterio L, Jankaricova M, Sciarrone MT, Barlassina C, et al. (2005) Role of the adducin family genes in human essential hypertension. J Hypertens 23: 543-549.
174. Morrison AC, Bray MS, Folsom AR, Boerwinkle E, (2002) ADD1 460W allele associated with cardiovascular disease in hypertensive individuals. Hypertension 39: 1053-1057.
175. Sarzani R, Cusi D, Salvi F, Barlassina C, Macciardi F, et al. (2006) The 460Trp allele of alpha-adducin increases carotid intima-media thickness in young adult males. J Hypertens 24: 697-703.
176. van Rijn MJ, Bos MJ, Yazdanpanah M, Isaacs A, Arias-Vasquez A, et al. (2006) Alpha-adducin polymorphism, atherosclerosis, and cardiovascular and cerebrovascular risk. Stroke 37: 2930-2934.
177. Perticone F, Sciacqua A, Barlassina C, Del Vecchio L, Signorello MC, et al. (2007) Gly460Trp alpha-adducin gene polymorphism and endothelial function in untreated hypertensive patients. J Hypertens 25: 2234-2239.
178. Manunta P, Lavery G, Lanzani C, Braund PS, Simonini M, et al. (2008) Physiological interaction between alpha-adducin and WNK1-NEDD4L pathways on sodium-related blood pressure regulation. Hypertension 52: 366-372.
179. Cappuzzello C, Melchionna R, Mangoni A, Tripodi G, Ferrari P, et al. (2007) Role of rat alpha adducin in angiogenesis: null effect of the F316Y polymorphism. Cardiovasc Res 75: 608-617.
180. Fischer I, Cochary EF, Konola JT, Romano-Clark G, (1991) Expression of plasmolipin in oligodendrocytes. J Neurosci Res 28: 81-89.
181. Miller AD, Bergholz U, Ziegler M, Stocking C, (2008) Identification of the myelin protein plasmolipin as the cell entry receptor for Mus caroli endogenous retrovirus. J Virol 82: 6862-6868.
182. Aston C, Jiang L, Sokolov BP, (2004) Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res 77: 858-866.
183. Aston C, Jiang L, Sokolov BP, (2005) Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 10: 309-322.
184. Malin D, Kim IM, Boetticher E, Kalin TV, Ramakrishna S, et al. (2007) Forkhead box F1 is essential for migration of mesenchymal cells and directly induces integrin-beta3 expression. Mol Cell Biol 27: 2486-2498.
185. Astorga J, Carlsson P, (2007) Hedgehog induction of murine vasculogenesis is mediated by Foxf1 and Bmp4. Development 134: 3753-3761.
186. Ormestad M, Astorga J, Landgren H, Wang T, Johansson BR, et al. (2006) Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production. Development 133: 833-843.
187. Kalin TV, Meliton L, Meliton AY, Zhu X, Whitsett JA, et al. (2008) Pulmonary mastocytosis and enhanced lung inflammation in mice heterozygous null for the Foxf1 gene. Am J Respir Cell Mol Biol 39: 390-399.
188. Zirn B, Samans B, Wittmann S, Pietsch T, Leuschner I, et al. (2006) Target genes of the WNT/beta-catenin pathway in Wilms tumors. Genes Chromosomes Cancer 45: 565-574.
189. Jukkola T, Sinjushina N, Partanen J, (2004) Drapc1 expression during mouse embryonic development. Gene Expr Patterns 4: 755-762.
190. Shimomura Y, Agalliu D, Vonica A, Luria V, Wajid M, et al. (2010) APCDD1 is a novel Wnt inhibitor mutated in hereditary hypotrichosis simplex. Nature 464: 1043-1047.
191. Kang P, Lee HK, Glasgow SM, Finley M, Donti T, et al. (2012) Sox9 and NFIA coordinate a transcriptional regulatory cascade during the initiation of gliogenesis. Neuron 74: 79-94.
192. Bost F, Diarra-Mehrpour M, Martin JP, (1998) Inter-alpha-trypsin inhibitor proteoglycan family-a group of proteins binding and stabilizing the extracellular matrix. Eur J Biochem 252: 339-346.
193. Hamm A, Veeck J, Bektas N, Wild PJ, Hartmann A, et al. (2008) Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis. BMC Cancer 8: 25.
194. Anveden A, Sjoholm K, Jacobson P, Palsdottir V, Walley AJ, et al. (2012) ITIH-5 expression in human adipose tissue is increased in obesity. Obesity (Silver Spring) 20: 708-714.
195. Veeck J, Chorovicer M, Naami A, Breuer E, Zafrakas M, et al. (2008) The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation. Oncogene 27: 865-876.
196. Street VA, McKee-Johnson JW, Fonseca RC, Tempel BL, Noben-Trauth K, (1998) Mutations in a plasma membrane Ca2+-ATPase gene cause deafness in deafwaddler mice. Nat Genet 19: 390-394.
197. Holton M, Mohamed TM, Oceandy D, Wang W, Lamas S, et al. (2010) Endothelial nitric oxide synthase activity is inhibited by the plasma membrane calcium ATPase in human endothelial cells. Cardiovasc Res 87: 440-448.
198. Ning M, Sarracino DA, Kho AT, Guo S, Lee SR, et al. (2011) Proteomic temporal profile of human brain endothelium after oxidative stress. Stroke 42: 37-43.
199. Qian WJ, Kaleta DT, Petritis BO, Jiang H, Liu T, et al. (2008) Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy. Mol Cell Proteomics 7: 1963-1973.
200. Liu T, Qian WJ, Gritsenko MA, Xiao W, Moldawer LL, et al. (2006) High dynamic range characterization of the trauma patient plasma proteome. Mol Cell Proteomics 5: 1899-1913.
201. Liu T, Qian WJ, Gritsenko MA, Camp DG 2nd, Monroe ME, et al (2005) Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J Proteome Res 4: 2070-2080.
202. Muthusamy B, Hanumanthu G, Suresh S, Rekha B, Srinivas D, et al. (2005) Plasma Proteome Database as a resource for proteomics research. Proteomics 5: 3531-3536.
203. Ping P, Vondriska TM, Creighton CJ, Gandhi TK, Yang Z, et al. (2005) A functional annotation of subproteomes in human plasma. Proteomics 5: 3506-3519.
204. Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, et al. (2005) Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5: 3226-3245.
205. Sharp FR, Xu H, Lit L, Walker W, Apperson M, et al. (2006) The future of genomic profiling of neurological diseases using blood. Arch Neurol 63: 1529-1536.
206. Lim YC, Luscinskas FW, (2006) Isolation and culture of murine heart and lung endothelial cells for in vitro model systems. Methods Mol Biol 341: 141-154.
207. Takemoto M, Asker N, Gerhardt H, Lundkvist A, Johansson BR, et al. (2002) A new method for large scale isolation of kidney glomeruli from mice. Am J Pathol 161: 799-805.
208. Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, et al. (2006) The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24: 1151-1161.